Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 21, 2025 08:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology

Myriad Genetics announced a hereditary cancer risk assessment program study was published in Obstetrics & Gynecology (also known as The Green Journal).
January 15, 2025 08:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance

Myriad Genetics announces select preliminary fourth quarter and full year 2024 financial results and introduces full year 2025 financial guidance.
January 09, 2025 16:30 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

Myriad Genetics announced it signed an agreement with sports broadcaster Hannah Storm to promote the importance of knowing family cancer history.
January 08, 2025 11:27 ET | Source: Myriad Genetics, Inc.

UPDATE – Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Paul J. Diaz, President and CEO, and Sam Raha, COO, Myriad Genetics, will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference.
January 08, 2025 08:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Paul J. Diaz, President and CEO, and Sam Raha, COO, Myriad Genetics, will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference.
January 07, 2025 08:00 ET | Source: Myriad Genetics, Inc.

MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay

The University of Texas MD Anderson Cancer Center and Myriad Genetics announced a five-year strategic alliance.
January 06, 2025 08:00 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report

Myriad Genetics released its Quality, Innovation, and Corporate Responsibility Report.
December 19, 2024 16:15 ET | Source: Myriad Genetics, Inc.

Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

Myriad Genetics announced a MyRisk® Hereditary Cancer Test with RiskScore® study was named as one of the top 10 significant advances in genomic medicine.
December 10, 2024 18:26 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Provides Update on Discussions with UnitedHealthcare regarding Medical Policy for Pharmacogenetic Testing

Myriad Genetics provides update on discussions with UnitedHealthcare regarding medical policy for pharmacogenetic testing.
December 10, 2024 16:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Expands Board of Directors with Election of Mark S. Davis as New Board Member

Myriad Genetics announced the election of Mark S. Davis to its Board of Director, effective immediately, expanding the Board from eight to nine members.

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right